Memorial Sloan Kettering Cancer Center
Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on Angiokinase Inhibitors, Immunotherapy Options, and Combination Strategies?
By
Memorial Sloan Kettering Cancer Center
FEATURING
Marjorie Zauderer
By
Memorial Sloan Kettering Cancer Center
FEATURING
Marjorie Zauderer
Login to view comments.
Click here to Login